Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma (Untreated Primary Disease).

Trial Profile

Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma (Untreated Primary Disease).

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Mogamulizumab (Primary) ; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisolone; Ranimustine; Vincristine; Vindesine
  • Indications Adult T-cell leukaemia-lymphoma
  • Focus Therapeutic Use
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 01 Jun 2015 Results published in the British Journal of Haematology.
    • 23 Jul 2013 Results published in a Kyowa Hakko Kirin media release; this trial supports an application for approval of mogamulizumab in a new indication
    • 31 May 2013 Primary endpoint 'Complete-clinical-response-rate' has been met based on information reported in an ASCO-2013 abstract.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top